Navigation Links
ARUP Laboratories Announces New CMO Appointment
Date:7/6/2009

SALT LAKE CITY, July 6 /PRNewswire/ -- ARUP Laboratories, a national clinical and anatomic pathology reference laboratory and a leader in innovative laboratory research and development, announced today the appointment of Sherrie L. Perkins, MD, PhD, as chief medical officer (CMO) and director of laboratories, effective, July 1, 2009.

Dr. Perkins will be taking over the responsibility from Edward R. Ashwood, MD, who will be transitioning into the role of president and chief executive officer. These transitions will coincide with the announced retirement of ARUP founder and CEO Carl R. Kjeldsberg, MD, on June 30, 2009.

"Dr. Perkins is uniquely qualified to lead ARUP into the future. She has shown superb leadership and a commitment to advancing patient care through laboratory medicine," said Dr. Ashwood.

Dr. Perkins has been with ARUP Laboratories and the University of Utah for 19 years. During this time, she has served in numerous leadership roles including director of hematopathology, interim department chair, and, for the past three years, as a member of the ARUP Laboratories executive management team. She is a tenured professor at the University of Utah School of Medicine, is board certified in anatomic pathology and holds a special qualification in hematology.

Dr. Perkins received her PhD in biochemistry from the University of Miami. She earned her MD and completed her pathology residency at Washington University.

"ARUP has a distinguished history of improving patient care, research, and medical education. I look forward to working with my colleagues to build upon this history," remarked Dr. Perkins.

About ARUP Laboratories

ARUP Laboratories is a national clinical and anatomic pathology reference laboratory and an enterprise of the University of Utah and its Department of Pathology. With more than 2,600 employees, ARUP offers over 2,000 tests and test combinations, ranging from routine screening tests to highly esoteric molecular and genetic assays, for patients throughout the country. ARUP's clients include more than half of the nation's university teaching hospitals and children's hospitals, as well as multihospital groups, major commercial laboratories, group purchasing organizations, military and government facilities, and major clinics. In addition, ARUP is a worldwide leader in innovative laboratory research and development, led by the efforts of the ARUP Institute for Clinical and Experimental Pathology(R). For more information about ARUP Laboratories, including a high-resolution, downloadable photo of Dr. Perkins, please visit http://www.aruplab.com/AboutARUP/PressRoom/PressRelease/2009/2009.07.06.jsp.


'/>"/>
SOURCE ARUP Laboratories
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2010 First Quarter Earnings
2. Caraco Pharmaceutical Laboratories, Ltd. Announces an Indefinite Reduction in its Workforce
3. Caraco Pharmaceutical Laboratories, Ltd. Updates on Financial Position
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Action
5. Forest Laboratories Announces Positive Top-line Data from Two Pivotal Phase III Trials of Ceftaroline for the Treatment of Community-acquired Bacterial Pneumonia (CABP) Requiring Hospitalization
6. AirClic Mobile Business Solutions Clic for Bio-Reference Laboratories, Inc.
7. M.A.Z.E. Cord Blood Laboratories Offers Expectant Parents The Chance To Win A $500 Savings Bond
8. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Fiscal Year 2009, Updates on FDA Inspection
9. IDEXX Laboratories to Present at William Blair 29th Annual Growth Stock Conference
10. Underwriters Laboratories Reminds Parents to Pay Attention to Staycation Safety Hazards
11. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Roxicodone(R) Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... ... seeking public support to bring their novel lifesaving device for the everyday use ... with medical-grade sensors, specially designed to read a child’s vital signs, and detect ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... are expected to be diagnosed globally; approximately 25,000 of them will be malignant.(1) ... greater use of this type of healthcare model in the diagnosis and treatment ...
(Date:4/24/2017)... ... April 24, 2017 , ... Come to PAINWeekEnd (PWE) Tampa on May 20 ... an educational and exciting 2-day program. , An attendee at a recent PAINWeekEnd ... approach patients” about the course entitled Ain't Misbehavin': Decreasing and Managing Pain Patient Aberrant ...
(Date:4/24/2017)... ... April 24, 2017 , ... “Learning to Use Your SPIRITUAL COMPASS To Navigate ... Use Your SPIRITUAL COMPASS To Navigate Life Issues” is the creation of published author, ... the Board of Directors for CONTACT USA, and former member of the American Association ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... the development of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic ... manufacture its ANCD BRAIN device as the product advances towards regulatory and clinical ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
(Date:4/18/2017)... April 18, 2017  Cardinal Health (NYSE: ... fiscal 2017 earnings per share (EPS) guidance and providing ... is in conjunction with this morning,s announcement of the ... and Nutritional Insufficiency businesses. Cardinal Health now ... will be at the bottom of its previous guidance ...
(Date:4/18/2017)... BLOOMINGTON, Minn. , April 18, 2017 ... ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, and Cameron ... announced the signing of a three-year exclusive sales ... deploy a dedicated sales team to introduce Imprimis, ... primarily focused in 13 states in the U.S. ...
Breaking Medicine Technology: